January 7, 2021
Catie describes herself as determined, balanced, and energetic
Catie graduated from Boise State University with a Bachelor of Science degree in Health Science Studies and a minor in Biology in May of 2019. Catie was a Dr. Ralph Jones FACS Pre-Medical Summer Fellowship recipient and a member of the Honors College during her time at Boise State University. She also was awarded the Frank Wong Pre-Med Scholarship 2017-2018. A Boise, Idaho native she has started her first year of medical school at the University of Utah School of Medicine in Salt Lake City, Utah, and would like to share her experience at Boise State, current career, and profession. Below are a few questions and Catie Bautista’s responses:
Utah s governors: A look at the 17 people who have led the state so far
kjzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kjzz.com Daily Mail and Mail on Sunday newspapers.
The Top Pediatric Articles of 2019
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
New Target Can Prevent Type 1 Diabetes
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.
Researchers identify new therapeutic target to treat patients with type 1 diabetes
Researchers at the University of Utah School of Medicine have identified a new therapeutic target to treat patients with type 1 diabetes. The study, which will be published December 9 in the
Journal of Experimental Medicine (
JEM), reveals that inhibiting a protein called OCA-B protects mice from type 1 diabetes by limiting the activity of immune cells that would otherwise destroy the pancreas insulin-producing β cells.
Type 1 diabetes is an autoimmune disease in which the body s immune system mistakenly attacks pancreatic β cells, cutting off the production of insulin. Patients require life-long insulin therapy to maintain appropriate blood glucose levels. At present, there are no treatments that can prevent the immune system from targeting β cells while preserving its ability to fight infection.